| Heading: |
|
| Question ID: |
1759456 |
| UIN: |
27015 |
| House: |
Commons |
| Date tabled: |
2025-01-28 |
| Asking Member ID: |
5334 |
| Asking Member display name: |
Dr Allison Gardner
|
| Asking Member handle: |
AllisonCGardner
|
| Asking Member Twitter reference: |
@AllisonCGardner
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what progress his Department has made on tackling the shortage of Pancreatic Enzyme Replacement Therapy drugs. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-02-05 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to boost production to mitigate the supply issue. Increased volumes of PERT are expected for 2025, and specialist importers have sourced unlicensed s... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |